Area of research
Hematology · Oncology
Research interest
Research focused on RNA-binding protein and Berberine, with related work in XRCC3, Odds ratio, Myeloid leukemia. Notable publications include 'The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression', 'Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease', and 'Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension'.
A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of <i>JAK2</i>-mutated post-MPN AML
A novel zinc finger protein gene signature for prognostic prediction, tumor microenvironment characterization, and therapeutic response in uterine corpus endometrial carcinoma
Post‐hospitalization rehabilitation alleviates long‐term immune repertoire alteration in COVID‐19 convalescent patients
HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States
Corrigendum to ‘Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer’
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer